ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Inflammation"

  • Abstract Number: 1544 • ACR Convergence 2020

    Tc99m Tilmanocept Imaging Is an Early Predictor of Clinical Response in Rheumatoid Arthritis Patients Beginning New Anti-TNFα Therapy

    Mara Leach1, David Ralph1, Beth Potter1, Bonnie Abbruzzese1, Rachael Hershey1, Jessica Fitzpatrick1, Katherine Repp1, Haya Shakhtra1, Madison Palmer1, Nicole Korczak1, Audrey Villarosa1, Michael Blue1, Martin Jacobs2, Yelliann Ruis3, Debbie Foley4, Alan Kivitz5 and Michael Rosol1, 1Navidea Biopharmaceuticals, Dublin, 2Kettering Medical Center, Kettering, 3Innovation Medical Research Center, Palmetto Bay, 4Premier Rheumatology of Oklahoma, Tulsa, 5Altoona Center for Clinical Research/Altoona Arthritis and Osteoporosis Center, Duncansville, PA

    Background/Purpose: Rheumatoid Arthritis (RA) is a serious and potentially debilitating disease, but low disease activity and even clinical remission can be obtained if an effective…
  • Abstract Number: 1931 • ACR Convergence 2020

    Effect of Cumulative Glucocorticoid Dose and Inflammation on Weight Change During Treatment of Giant Cell Arteritis

    Naomi Serling-Boyd1, Xiaoqing Fu2, Yuqing Zhang3, Sebastian Unizony1, Zachary Wallace4, Hyon Choi5 and John H. Stone6, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, 3Massachusetts General Hospital, Quincy, MA, 4Massachusetts General Hospital, Newton, MA, 5Massachusetts General Hospital, Department of Medicine, Division of Rheumatology, Lexington, MA, 6Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

    Background/Purpose: Giant cell arteritis (GCA) is a form of large vessel vasculitis that requires treatment with high-dose, long-term glucocorticoids (GC). Weight gain, among other side-effects…
  • Abstract Number: 025 • 2020 Pediatric Rheumatology Symposium

    HLA Genetic Signatures Associated with Inflammatory Sub-type in Juvenile Localized Scleroderma

    Christina Schutt1, Emily Mirizio 2, Kaila Schollaert-Fitch 2 and Kathryn Torok 2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, 2Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh

    Background/Purpose: Juvenile localized scleroderma (jLS) is an autoimmune disease of the skin and underlying tissue that is characterized by an earlier inflammatory infiltrate, followed by…
  • Abstract Number: L10 • 2019 ACR/ARP Annual Meeting

    Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

    Roberta Gualtierotti1, Francesca Ingegnoli 2, Massimo Boscolo 3, Samantha Griffini 3, Elena Grovetti 4 and Massimo Cugno 5, 1Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Lombardia, Italy, 2UOC Reumatologia Clinica, ASST Pini-CTO, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy, 3Medicina Interna, Ospedale Maggiore Policlinico, IRCCS Fondazione Ca' Granda Milano, Italy, Milan, 4Medicina Interna, Ospedale Maggiore Policlinico, IRCCS Fondazione Ca' Granda Milano, Milan, 5Medicina Interna, Ospedale Maggiore Policlinico, IRCCS Fondazione Ca' Granda Milano, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease associated with a prothrombotic state. Tocilizumab, an interleukin-6 receptor inhibitor, is highly effective in controlling…
  • Abstract Number: 2355 • 2019 ACR/ARP Annual Meeting

    Antirheumatic Therapy Is Associated with Reduced Complement Activation in Rheumatoid Arthritis

    Thao Nguyen1, Ingrid Hokstad 2, Gia Deyab 3, Tom Eirik Mollnes 4, Stefan Agewall 4, Morten Fagerland 4, Gro Eilertsen 5, Mark Feinberg 6, Knut Mikkelsen 2, Øystein Førre 4 and Ivana Hollan 7, 1Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 2Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Oppland, Norway, 3Innlandet Hospital Trust, Bærum, Akershus, Norway, 4Oslo University Hospital, Oslo, Norway, 5The Artic University of Norway, Tromsø, Norway, 6Harvard Medical School and Brigham and Women´s Hospital, Boston, Boston, MA, 7Lillehammer Hospital for Rheumatic Diseases and Brigham and Women’s Hospital, Boston, Lillehammer, Oppland, Norway

    Background/Purpose: Inflammation and immune dysregulation appear to significantly contribute to increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). The complement system is a…
  • Abstract Number: 2779 • 2019 ACR/ARP Annual Meeting

    Higher Disease Activity Is Associated with More Spinal Radiographic Progression in Patients with Axial Spondyloarthritis Independently of Prior Exposure to TNF Inhibitors

    Alexandre Sepriano1, Sofia Ramiro 2, Stephanie Wichuk 3, Praveena Chiowchanwisawakit 4, Terrie MacCosham 3, Joel Paschke 5, Désirée van der Heijde 1, Robert B.M. Landewé 6 and Walter Maksymowych 7, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands, 3University of Alberta, Edmonton, Canada, 4Mahidol University, Bangkok, Thailand, 5CARE Arthritis, Edmonton, Canada, 6Amsterdam University Medical Center, Amsterdam, Netherlands, 7University of Alberta and CARE Arthritis, Edmonton, Canada

    Background/Purpose: The association between disease activity and spinal radiographic progression in radiographic axial spondyloarthritis (r-axSpA) has been previously shown in a cohort of patients (pts)…
  • Abstract Number: 4 • 2019 ACR/ARP Annual Meeting

    AMP Deaminase 2 Surface Expression Counteracting CD73-Driven Generation of Anti-Inflammatory Extracellular Adenosine

    Lisa Ehlers1, Aditi Kuppe 1, Cindy Strehl 1, Marieluise Kirchner 2, Frank Buttgereit 3 and Timo Gaber 1, 1Charite University Hospital Berlin, Berlin, Germany, 2Max Delbrück Center for Molecular Medicine, BIH Core Facility Proteomics, Berlin, Germany, 3Charité-Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Adenosine and its nucleotides represent crucial immunomodulators in the extracellular environment. ATP and ADP are released from stressed cells in states of inflammation, whereas…
  • Abstract Number: 24 • 2019 ACR/ARP Annual Meeting

    Role of Trained Immunity in the Pathogenesis of Erdheim-Chester Disease

    Giulio Cavalli1, Riccardo Biavasco 1, Marina Ferrarini 2, Elisabetta Ferrero 2, Eugenio Montini 2, Simone Cenci 2, Cardaci Simone 2 and Lorenzo Dagna 1, 1Vita-Salute San Raffaele University, Milan, Italy, 2IRCCS San Raffaele Hospital, Milan, Italy

    Background/Purpose: Erdheim-Chester disease (ECD) is a chronic inflammatory disease characterized by infiltration of bone and other tissues by foamy macrophages. These cells exhibit activating mutations…
  • Abstract Number: 27 • 2019 ACR/ARP Annual Meeting

    Altered Inflammatory Response of Macrophages in the Fosl-2 Transgenic Mouse Model of Systemic Sclerosis

    Chantal Rufer 1, Michal Rudnik1, Siim Uhtjärv 1, Mara Stellato 1, Florian Renoux 2, Oliver Distler 3 and Gabriela Kania 1, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, 3Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland

    Background/Purpose: Fos-like 2 (Fosl-2) is a transcription factor belonging to the Fos family of proteins which is part of the AP-1 transcription complex. The Fosl-2…
  • Abstract Number: 819 • 2019 ACR/ARP Annual Meeting

    The Long Noncoding RNA HOTTIP Regulates Cell Cycle and Inflammatory Response in Hand Synovial Fibroblasts

    Mojca Frank-Bertoncelj 1, Tadeja Kuret2, Ana Županič 3, Snezna Sodin-Semrl 4, Oliver Distler 5 and Caroline Ospelt 1, 1University Hospital Zürich, Zürich, Switzerland, 2University Hospital Zürich, Zurich, Tajikistan, 3University Hospital Zürich, Zurich, Switzerland, 4University Medical Center Ljubljana, Ljubljana, Slovenia, 5Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland

    Background/Purpose: Previously we showed that the long noncoding RNA (lncRNA) HOTTIP is exclusively expressed in synovial fibroblasts (SF) from distal joints, such as small joints…
  • Abstract Number: 854 • 2019 ACR/ARP Annual Meeting

    Do Smoking and Socio-economic Factors Independently Influence Imaging Outcomes in Axial Spondyloarthritis? Five-year Data from the DESIR Cohort

    Elena Nikiphorou1, Sofia Ramiro 2, Alexandre Sepriano 3, Adeline Ruyssen Witrand 4, Robert B.M. Landewé 5 and Désirée van der Heijde 3, 1King's College London, London, United Kingdom, 2Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology center, Pierre Paul Riquet Hospital, CHU of Toulouse, Paul Sabatier University, UMR 1027, Inserm, France, Toulouse, France, 5Amsterdam University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Smoking and systemic inflammation have been shown to independently associate with radiographic spinal progression in patients with axSpA. Evidence suggests that certain socioeconomic (SE)…
  • Abstract Number: 887 • 2019 ACR/ARP Annual Meeting

    Critical Role of the Cholinergic System Involvement in Osteoarthritis

    Alice Courties1, Ariane Do 1, Sarah Leite 2, Audrey Pigenet 2, Morgane Belle 3, Geoffroy Nourissat 4, Alain Sautet 5, Alain Chedotal 3, Uwe Maskos 6, Francis Berenbaum 7 and Jérémie Sellam 1, 1Service de Rhumatologie, AP-HP Hôpital Saint-Antoine, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 2Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 3Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France, Paris, France, 4Chirurgie orthopédique, Clinique Maussins, Groupe Ramsay générale de santé, 67 rue de Romainville, 75019, Paris, Paris, France, 5Chirurgie orthopédique, AP-HP Hôpital Saint-Antoine, Paris, Paris, France, 6Unité de neurobiologie intégrative des systèmes cholinergiques, CNRS UMR 3571, Institut Pasteur, Paris, Paris, France, 7Sorbonne Université-Inserm CDR Saint-Antoine, AP-HP, Paris, France

    Background/Purpose: The efferent vagus nerve can regulate inflammation via its principal neurotransmitter acetylcholine (ACh), a concept referred as the 'cholinergic anti-inflammatory pathway'. ACh interacts with members of…
  • Abstract Number: 979 • 2019 ACR/ARP Annual Meeting

    Platelet Derived Growth Factor Receptor Alpha (PDGFRα) Blockade Inhibits Arthritis in Mice

    Bhanupriya Madarampalli1, Paul Panipinto 1, Erica Chow 1, Kendahl Sugai 1, Fanqi Shi 1 and Erika Noss 1, 1University of Washington, Seattle, WA

    Background/Purpose: The interplay between infiltrating immune cells and activated joint stromal cells drives inflammation, cartilage destruction, and bone erosion in rheumatoid arthritis (RA). Among joint…
  • Abstract Number: 1228 • 2019 ACR/ARP Annual Meeting

    Soluble Triggering Receptor Expressed on Myeloid cells-1 (sTREM-1) Ameliorates Monosodium Urate Crystals (MSUC)-induced Inflammation in a Mouse Air-pouch Model of Gout

    Vitaly Kliminski 1 and Yair Molad2, 1Laboratory of Inflammation Research, Felsenstein Medical Research Center, Tel Aviv University, Petach Tikva, Israel, 2Rabin Medical Center, Beilinson Hospital, and Tel Aviv University, Petach Tikva, HaMerkaz, Israel

    Background/Purpose: Myeloid cells membrane-bound TREM-1 (mTREM-1) amplifies toll like receptor (TLR)-4-mediated myeloid cells activation, accompanied by release of soluble TREM-1 (sTREM-1) that acts as a…
  • Abstract Number: 1521 • 2019 ACR/ARP Annual Meeting

    Ixekizumab Is Effective in the Treatment of Radiographic Axial Spondyloarthritis Regardless of the Level of C-Reactive Protein or Magnetic Resonance Imaging Scores

    Walter P. Maksymowych1, Gaia Gallo 2, Rebecca Bolce 3, Fangyi Zhao 2, Vladimir Geneus 3, Mikkel Østergaard 4, Kurisu Tada 5, Atul Deodhar 6 and Lianne Gensler 7, 1University of Alberta/CARE ARTHRITIS, Edmonton, AB, Canada, 2Eli Lilly and Company, Indianapolis, IN, 3Eli Lilly and Company, Indianapolis, 4Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 5Juntendo University School of Medicine, Tokyo, Japan, 6Oregon Health & Science University, Portland, OR, 7University San Francisco California, San Francisco, CA

    Background/Purpose: IL-17 plays an important role in the pathogenesis of radiographic axial spondyloarthritis (r-axSpA). Elevated CRP levels in serum predict response to TNF inhibitors (TNFi).1-4…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology